Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isoflurane versus propofol anesthesia during hepatectomy in cirrhotic patients with primary liver cancer
ACTRN12610000063011Phase 4Completed
- Sponsor
- Shanghai Rising-Star Program
- Start
- Dec 2008
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in hepatocellular carcinoma (HCC) and Cirrhosis comparing Isoflurane arm with Propofol control arm (2 arms). Primary endpoint: Postoperative liver function and hepatocyte injury. Started Dec 2008; status: completed.
02
Drugs
isofluranepropofol
03
Conditions
hepatocellular carcinoma (HCC)Cirrhosis
Beyond the preview
Go deeper on ACTRN12610000063011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000063011.